Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Well-Differentiated Neuroendocrine Tumors
NCT02279758Phase 2Unknown
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Mar 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in neuroendocrine tumors (NETs), sponsored by Instituto do Câncer do Estado de São Paulo. Status: unknown.
02
Drugs
metformin
03
Conditions
neuroendocrine tumors (NETs)
Beyond the preview
Go deeper on NCT02279758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279758.